Chen Serene I, Dharmarajan Kumar, Kim Nancy, Strait Kelly M, Li Shu-Xia, Safavi Kyan C, Lindenauer Peter K, Krumholz Harlan M, Lagu Tara
Yale University School of Medicine, New Haven, CT, USA.
Circ Cardiovasc Qual Outcomes. 2012 May;5(3):308-13. doi: 10.1161/CIRCOUTCOMES.112.966069. Epub 2012 May 10.
The intensive practice style of hospitals with high procedure rates may result in higher costs of care for medically managed patients. We sought to determine how costs for patients with heart failure (HF) not receiving procedures compare between hospital groups defined by their overall use of procedures.
We identified all 2009 to 2010 adult HF hospitalizations in hospitals capable of performing invasive procedures that had at least 25 HF hospitalizations in the Perspective database from Premier, Inc. We divided hospitals into 2 groups by the proportion of patients with HF receiving invasive percutaneous or surgical procedures: low (>0%-10%) and high (≥ 10%). The standard costs of hospitalizations at each hospital were risk adjusted using patient demographics and comorbidities. We used the Wilcoxon rank sum test to assess cost, length of stay, and mortality outcome differences between the 2 groups. Median risk-standardized costs among low-procedural HF hospitalizations were $5259 (interquartile range, $4683-$6814) versus $6965 (interquartile range, $5981-$8235) for hospitals with high procedure use (P<0.001). Median length of stay was 4 days for both groups. Risk-standardized mortality rates were 5.4% (low procedure) and 5.0% (high procedure) (P=0.009). We did not identify any single service area that explained the difference in costs between hospital groups, but these hospitals had higher costs for most service areas.
Among patients who do not receive invasive procedures, the cost of HF hospitalization is higher in more procedure-intense hospitals compared with hospitals that perform fewer procedures.
手术率高的医院的强化医疗模式可能导致接受药物治疗的患者的护理成本更高。我们试图确定在根据手术总体使用情况定义的医院组之间,未接受手术的心力衰竭(HF)患者的费用情况如何。
我们在Premier公司的透视数据库中,确定了2009年至2010年期间所有能够进行侵入性手术且至少有25例HF住院患者的医院中的成年HF住院患者。我们根据接受侵入性经皮或外科手术的HF患者比例将医院分为两组:低(>0%-10%)和高(≥10%)。使用患者人口统计学和合并症对每家医院的住院标准费用进行风险调整。我们使用Wilcoxon秩和检验来评估两组之间的费用、住院时间和死亡率结果差异。低手术量HF住院患者的中位风险标准化费用为5259美元(四分位间距,4683美元至6814美元),而手术量高的医院为6965美元(四分位间距,5981美元至8235美元)(P<0.001)。两组的中位住院时间均为4天。风险标准化死亡率分别为5.4%(低手术量)和5.0%(高手术量)(P=0.009)。我们未发现任何单一服务领域能够解释医院组之间的费用差异,但这些医院在大多数服务领域的费用更高。
在未接受侵入性手术的患者中,与手术量较少的医院相比,手术量较大的医院中HF住院费用更高。